Moderna's Q2 Report Expected to Be Unremarkable Ahead of Key Data Readouts
Moderna is set to report its second-quarter earnings on July 31, which Jefferies analysts expect will be uneventful due to declining seasonal vaccine sales and a focus on late-stage pipeline updates. The firm forecasts revenue between $50 million and $100 million for Q2, down from the first quarter's $389 million.